Global Hydrogel-based Drug Delivery Device Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Hydrogel-based Drug Delivery Device market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
This report is a detailed and comprehensive analysis for global Hydrogel-based Drug Delivery Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Hydrogel-based Drug Delivery Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Hydrogel-based Drug Delivery Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Hydrogel-based Drug Delivery Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Hydrogel-based Drug Delivery Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hydrogel-based Drug Delivery Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hydrogel-based Drug Delivery Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca Plc., Columbia Laboratories Inc., Mylan, Teva Pharmaceuticals USA Inc., Blairex Laboratories Inc., ARx LLC., Endo International plc, BioDelivery Sciences International Inc., Indivior PLC, GSK Plc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Hydrogel-based Drug Delivery Device market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hydrogel-based Drug Delivery Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hydrogel-based Drug Delivery Device, with price, sales quantity, revenue, and global market share of Hydrogel-based Drug Delivery Device from 2020 to 2025.
Chapter 3, the Hydrogel-based Drug Delivery Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hydrogel-based Drug Delivery Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Hydrogel-based Drug Delivery Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hydrogel-based Drug Delivery Device.
Chapter 14 and 15, to describe Hydrogel-based Drug Delivery Device sales channel, distributors, customers, research findings and conclusion.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
This report is a detailed and comprehensive analysis for global Hydrogel-based Drug Delivery Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Hydrogel-based Drug Delivery Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Hydrogel-based Drug Delivery Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Hydrogel-based Drug Delivery Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Hydrogel-based Drug Delivery Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hydrogel-based Drug Delivery Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hydrogel-based Drug Delivery Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca Plc., Columbia Laboratories Inc., Mylan, Teva Pharmaceuticals USA Inc., Blairex Laboratories Inc., ARx LLC., Endo International plc, BioDelivery Sciences International Inc., Indivior PLC, GSK Plc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Hydrogel-based Drug Delivery Device market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Oral
- Buccal
- Rectal
- Vaginal
- Other
- Hospital
- Clinic
- Other
- AstraZeneca Plc.
- Columbia Laboratories Inc.
- Mylan
- Teva Pharmaceuticals USA Inc.
- Blairex Laboratories Inc.
- ARx LLC.
- Endo International plc
- BioDelivery Sciences International Inc.
- Indivior PLC
- GSK Plc
- Pfizer Inc.
- Aquestive Therapeutics Inc.
- ZIM LABORATORIES LIMITED
- IntelGenx Corp.
- NEXGEL
- Bliss GVS Pharma Ltd.
- Teika Pharmaceutical Co. Ltd.
- Medherant Limited
- Galderma
- Johnson & Johnson
- Bausch and Lomb
- Ferring B.V
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hydrogel-based Drug Delivery Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hydrogel-based Drug Delivery Device, with price, sales quantity, revenue, and global market share of Hydrogel-based Drug Delivery Device from 2020 to 2025.
Chapter 3, the Hydrogel-based Drug Delivery Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hydrogel-based Drug Delivery Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Hydrogel-based Drug Delivery Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hydrogel-based Drug Delivery Device.
Chapter 14 and 15, to describe Hydrogel-based Drug Delivery Device sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Hydrogel-based Drug Delivery Device Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Oral
1.3.3 Buccal
1.3.4 Rectal
1.3.5 Vaginal
1.3.6 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Hydrogel-based Drug Delivery Device Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Hydrogel-based Drug Delivery Device Market Size & Forecast
1.5.1 Global Hydrogel-based Drug Delivery Device Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Hydrogel-based Drug Delivery Device Sales Quantity (2020-2031)
1.5.3 Global Hydrogel-based Drug Delivery Device Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 AstraZeneca Plc.
2.1.1 AstraZeneca Plc. Details
2.1.2 AstraZeneca Plc. Major Business
2.1.3 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Product and Services
2.1.4 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 AstraZeneca Plc. Recent Developments/Updates
2.2 Columbia Laboratories Inc.
2.2.1 Columbia Laboratories Inc. Details
2.2.2 Columbia Laboratories Inc. Major Business
2.2.3 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Product and Services
2.2.4 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Columbia Laboratories Inc. Recent Developments/Updates
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Hydrogel-based Drug Delivery Device Product and Services
2.3.4 Mylan Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Mylan Recent Developments/Updates
2.4 Teva Pharmaceuticals USA Inc.
2.4.1 Teva Pharmaceuticals USA Inc. Details
2.4.2 Teva Pharmaceuticals USA Inc. Major Business
2.4.3 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Product and Services
2.4.4 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Teva Pharmaceuticals USA Inc. Recent Developments/Updates
2.5 Blairex Laboratories Inc.
2.5.1 Blairex Laboratories Inc. Details
2.5.2 Blairex Laboratories Inc. Major Business
2.5.3 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Product and Services
2.5.4 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Blairex Laboratories Inc. Recent Developments/Updates
2.6 ARx LLC.
2.6.1 ARx LLC. Details
2.6.2 ARx LLC. Major Business
2.6.3 ARx LLC. Hydrogel-based Drug Delivery Device Product and Services
2.6.4 ARx LLC. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 ARx LLC. Recent Developments/Updates
2.7 Endo International plc
2.7.1 Endo International plc Details
2.7.2 Endo International plc Major Business
2.7.3 Endo International plc Hydrogel-based Drug Delivery Device Product and Services
2.7.4 Endo International plc Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Endo International plc Recent Developments/Updates
2.8 BioDelivery Sciences International Inc.
2.8.1 BioDelivery Sciences International Inc. Details
2.8.2 BioDelivery Sciences International Inc. Major Business
2.8.3 BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Product and Services
2.8.4 BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 BioDelivery Sciences International Inc. Recent Developments/Updates
2.9 Indivior PLC
2.9.1 Indivior PLC Details
2.9.2 Indivior PLC Major Business
2.9.3 Indivior PLC Hydrogel-based Drug Delivery Device Product and Services
2.9.4 Indivior PLC Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Indivior PLC Recent Developments/Updates
2.10 GSK Plc
2.10.1 GSK Plc Details
2.10.2 GSK Plc Major Business
2.10.3 GSK Plc Hydrogel-based Drug Delivery Device Product and Services
2.10.4 GSK Plc Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 GSK Plc Recent Developments/Updates
2.11 Pfizer Inc.
2.11.1 Pfizer Inc. Details
2.11.2 Pfizer Inc. Major Business
2.11.3 Pfizer Inc. Hydrogel-based Drug Delivery Device Product and Services
2.11.4 Pfizer Inc. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Pfizer Inc. Recent Developments/Updates
2.12 Aquestive Therapeutics Inc.
2.12.1 Aquestive Therapeutics Inc. Details
2.12.2 Aquestive Therapeutics Inc. Major Business
2.12.3 Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Product and Services
2.12.4 Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Aquestive Therapeutics Inc. Recent Developments/Updates
2.13 ZIM LABORATORIES LIMITED
2.13.1 ZIM LABORATORIES LIMITED Details
2.13.2 ZIM LABORATORIES LIMITED Major Business
2.13.3 ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Product and Services
2.13.4 ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 ZIM LABORATORIES LIMITED Recent Developments/Updates
2.14 IntelGenx Corp.
2.14.1 IntelGenx Corp. Details
2.14.2 IntelGenx Corp. Major Business
2.14.3 IntelGenx Corp. Hydrogel-based Drug Delivery Device Product and Services
2.14.4 IntelGenx Corp. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 IntelGenx Corp. Recent Developments/Updates
2.15 NEXGEL
2.15.1 NEXGEL Details
2.15.2 NEXGEL Major Business
2.15.3 NEXGEL Hydrogel-based Drug Delivery Device Product and Services
2.15.4 NEXGEL Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 NEXGEL Recent Developments/Updates
2.16 Bliss GVS Pharma Ltd.
2.16.1 Bliss GVS Pharma Ltd. Details
2.16.2 Bliss GVS Pharma Ltd. Major Business
2.16.3 Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Product and Services
2.16.4 Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Bliss GVS Pharma Ltd. Recent Developments/Updates
2.17 Teika Pharmaceutical Co. Ltd.
2.17.1 Teika Pharmaceutical Co. Ltd. Details
2.17.2 Teika Pharmaceutical Co. Ltd. Major Business
2.17.3 Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Product and Services
2.17.4 Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Teika Pharmaceutical Co. Ltd. Recent Developments/Updates
2.18 Medherant Limited
2.18.1 Medherant Limited Details
2.18.2 Medherant Limited Major Business
2.18.3 Medherant Limited Hydrogel-based Drug Delivery Device Product and Services
2.18.4 Medherant Limited Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Medherant Limited Recent Developments/Updates
2.19 Galderma
2.19.1 Galderma Details
2.19.2 Galderma Major Business
2.19.3 Galderma Hydrogel-based Drug Delivery Device Product and Services
2.19.4 Galderma Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Galderma Recent Developments/Updates
2.20 Johnson & Johnson
2.20.1 Johnson & Johnson Details
2.20.2 Johnson & Johnson Major Business
2.20.3 Johnson & Johnson Hydrogel-based Drug Delivery Device Product and Services
2.20.4 Johnson & Johnson Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 Johnson & Johnson Recent Developments/Updates
2.21 Bausch and Lomb
2.21.1 Bausch and Lomb Details
2.21.2 Bausch and Lomb Major Business
2.21.3 Bausch and Lomb Hydrogel-based Drug Delivery Device Product and Services
2.21.4 Bausch and Lomb Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 Bausch and Lomb Recent Developments/Updates
2.22 Ferring B.V
2.22.1 Ferring B.V Details
2.22.2 Ferring B.V Major Business
2.22.3 Ferring B.V Hydrogel-based Drug Delivery Device Product and Services
2.22.4 Ferring B.V Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 Ferring B.V Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HYDROGEL-BASED DRUG DELIVERY DEVICE BY MANUFACTURER
3.1 Global Hydrogel-based Drug Delivery Device Sales Quantity by Manufacturer (2020-2025)
3.2 Global Hydrogel-based Drug Delivery Device Revenue by Manufacturer (2020-2025)
3.3 Global Hydrogel-based Drug Delivery Device Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Hydrogel-based Drug Delivery Device by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Hydrogel-based Drug Delivery Device Manufacturer Market Share in 2024
3.4.3 Top 6 Hydrogel-based Drug Delivery Device Manufacturer Market Share in 2024
3.5 Hydrogel-based Drug Delivery Device Market: Overall Company Footprint Analysis
3.5.1 Hydrogel-based Drug Delivery Device Market: Region Footprint
3.5.2 Hydrogel-based Drug Delivery Device Market: Company Product Type Footprint
3.5.3 Hydrogel-based Drug Delivery Device Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Hydrogel-based Drug Delivery Device Market Size by Region
4.1.1 Global Hydrogel-based Drug Delivery Device Sales Quantity by Region (2020-2031)
4.1.2 Global Hydrogel-based Drug Delivery Device Consumption Value by Region (2020-2031)
4.1.3 Global Hydrogel-based Drug Delivery Device Average Price by Region (2020-2031)
4.2 North America Hydrogel-based Drug Delivery Device Consumption Value (2020-2031)
4.3 Europe Hydrogel-based Drug Delivery Device Consumption Value (2020-2031)
4.4 Asia-Pacific Hydrogel-based Drug Delivery Device Consumption Value (2020-2031)
4.5 South America Hydrogel-based Drug Delivery Device Consumption Value (2020-2031)
4.6 Middle East & Africa Hydrogel-based Drug Delivery Device Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2031)
5.2 Global Hydrogel-based Drug Delivery Device Consumption Value by Type (2020-2031)
5.3 Global Hydrogel-based Drug Delivery Device Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2031)
6.2 Global Hydrogel-based Drug Delivery Device Consumption Value by Application (2020-2031)
6.3 Global Hydrogel-based Drug Delivery Device Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2031)
7.2 North America Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2031)
7.3 North America Hydrogel-based Drug Delivery Device Market Size by Country
7.3.1 North America Hydrogel-based Drug Delivery Device Sales Quantity by Country (2020-2031)
7.3.2 North America Hydrogel-based Drug Delivery Device Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2031)
8.2 Europe Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2031)
8.3 Europe Hydrogel-based Drug Delivery Device Market Size by Country
8.3.1 Europe Hydrogel-based Drug Delivery Device Sales Quantity by Country (2020-2031)
8.3.2 Europe Hydrogel-based Drug Delivery Device Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Hydrogel-based Drug Delivery Device Market Size by Region
9.3.1 Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Hydrogel-based Drug Delivery Device Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2031)
10.2 South America Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2031)
10.3 South America Hydrogel-based Drug Delivery Device Market Size by Country
10.3.1 South America Hydrogel-based Drug Delivery Device Sales Quantity by Country (2020-2031)
10.3.2 South America Hydrogel-based Drug Delivery Device Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Hydrogel-based Drug Delivery Device Market Size by Country
11.3.1 Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Hydrogel-based Drug Delivery Device Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Hydrogel-based Drug Delivery Device Market Drivers
12.2 Hydrogel-based Drug Delivery Device Market Restraints
12.3 Hydrogel-based Drug Delivery Device Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Hydrogel-based Drug Delivery Device and Key Manufacturers
13.2 Manufacturing Costs Percentage of Hydrogel-based Drug Delivery Device
13.3 Hydrogel-based Drug Delivery Device Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Hydrogel-based Drug Delivery Device Typical Distributors
14.3 Hydrogel-based Drug Delivery Device Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Hydrogel-based Drug Delivery Device Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Oral
1.3.3 Buccal
1.3.4 Rectal
1.3.5 Vaginal
1.3.6 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Hydrogel-based Drug Delivery Device Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Hydrogel-based Drug Delivery Device Market Size & Forecast
1.5.1 Global Hydrogel-based Drug Delivery Device Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Hydrogel-based Drug Delivery Device Sales Quantity (2020-2031)
1.5.3 Global Hydrogel-based Drug Delivery Device Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 AstraZeneca Plc.
2.1.1 AstraZeneca Plc. Details
2.1.2 AstraZeneca Plc. Major Business
2.1.3 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Product and Services
2.1.4 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 AstraZeneca Plc. Recent Developments/Updates
2.2 Columbia Laboratories Inc.
2.2.1 Columbia Laboratories Inc. Details
2.2.2 Columbia Laboratories Inc. Major Business
2.2.3 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Product and Services
2.2.4 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Columbia Laboratories Inc. Recent Developments/Updates
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Hydrogel-based Drug Delivery Device Product and Services
2.3.4 Mylan Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Mylan Recent Developments/Updates
2.4 Teva Pharmaceuticals USA Inc.
2.4.1 Teva Pharmaceuticals USA Inc. Details
2.4.2 Teva Pharmaceuticals USA Inc. Major Business
2.4.3 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Product and Services
2.4.4 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Teva Pharmaceuticals USA Inc. Recent Developments/Updates
2.5 Blairex Laboratories Inc.
2.5.1 Blairex Laboratories Inc. Details
2.5.2 Blairex Laboratories Inc. Major Business
2.5.3 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Product and Services
2.5.4 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Blairex Laboratories Inc. Recent Developments/Updates
2.6 ARx LLC.
2.6.1 ARx LLC. Details
2.6.2 ARx LLC. Major Business
2.6.3 ARx LLC. Hydrogel-based Drug Delivery Device Product and Services
2.6.4 ARx LLC. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 ARx LLC. Recent Developments/Updates
2.7 Endo International plc
2.7.1 Endo International plc Details
2.7.2 Endo International plc Major Business
2.7.3 Endo International plc Hydrogel-based Drug Delivery Device Product and Services
2.7.4 Endo International plc Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Endo International plc Recent Developments/Updates
2.8 BioDelivery Sciences International Inc.
2.8.1 BioDelivery Sciences International Inc. Details
2.8.2 BioDelivery Sciences International Inc. Major Business
2.8.3 BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Product and Services
2.8.4 BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 BioDelivery Sciences International Inc. Recent Developments/Updates
2.9 Indivior PLC
2.9.1 Indivior PLC Details
2.9.2 Indivior PLC Major Business
2.9.3 Indivior PLC Hydrogel-based Drug Delivery Device Product and Services
2.9.4 Indivior PLC Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Indivior PLC Recent Developments/Updates
2.10 GSK Plc
2.10.1 GSK Plc Details
2.10.2 GSK Plc Major Business
2.10.3 GSK Plc Hydrogel-based Drug Delivery Device Product and Services
2.10.4 GSK Plc Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 GSK Plc Recent Developments/Updates
2.11 Pfizer Inc.
2.11.1 Pfizer Inc. Details
2.11.2 Pfizer Inc. Major Business
2.11.3 Pfizer Inc. Hydrogel-based Drug Delivery Device Product and Services
2.11.4 Pfizer Inc. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Pfizer Inc. Recent Developments/Updates
2.12 Aquestive Therapeutics Inc.
2.12.1 Aquestive Therapeutics Inc. Details
2.12.2 Aquestive Therapeutics Inc. Major Business
2.12.3 Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Product and Services
2.12.4 Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Aquestive Therapeutics Inc. Recent Developments/Updates
2.13 ZIM LABORATORIES LIMITED
2.13.1 ZIM LABORATORIES LIMITED Details
2.13.2 ZIM LABORATORIES LIMITED Major Business
2.13.3 ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Product and Services
2.13.4 ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 ZIM LABORATORIES LIMITED Recent Developments/Updates
2.14 IntelGenx Corp.
2.14.1 IntelGenx Corp. Details
2.14.2 IntelGenx Corp. Major Business
2.14.3 IntelGenx Corp. Hydrogel-based Drug Delivery Device Product and Services
2.14.4 IntelGenx Corp. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 IntelGenx Corp. Recent Developments/Updates
2.15 NEXGEL
2.15.1 NEXGEL Details
2.15.2 NEXGEL Major Business
2.15.3 NEXGEL Hydrogel-based Drug Delivery Device Product and Services
2.15.4 NEXGEL Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 NEXGEL Recent Developments/Updates
2.16 Bliss GVS Pharma Ltd.
2.16.1 Bliss GVS Pharma Ltd. Details
2.16.2 Bliss GVS Pharma Ltd. Major Business
2.16.3 Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Product and Services
2.16.4 Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Bliss GVS Pharma Ltd. Recent Developments/Updates
2.17 Teika Pharmaceutical Co. Ltd.
2.17.1 Teika Pharmaceutical Co. Ltd. Details
2.17.2 Teika Pharmaceutical Co. Ltd. Major Business
2.17.3 Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Product and Services
2.17.4 Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Teika Pharmaceutical Co. Ltd. Recent Developments/Updates
2.18 Medherant Limited
2.18.1 Medherant Limited Details
2.18.2 Medherant Limited Major Business
2.18.3 Medherant Limited Hydrogel-based Drug Delivery Device Product and Services
2.18.4 Medherant Limited Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Medherant Limited Recent Developments/Updates
2.19 Galderma
2.19.1 Galderma Details
2.19.2 Galderma Major Business
2.19.3 Galderma Hydrogel-based Drug Delivery Device Product and Services
2.19.4 Galderma Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Galderma Recent Developments/Updates
2.20 Johnson & Johnson
2.20.1 Johnson & Johnson Details
2.20.2 Johnson & Johnson Major Business
2.20.3 Johnson & Johnson Hydrogel-based Drug Delivery Device Product and Services
2.20.4 Johnson & Johnson Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 Johnson & Johnson Recent Developments/Updates
2.21 Bausch and Lomb
2.21.1 Bausch and Lomb Details
2.21.2 Bausch and Lomb Major Business
2.21.3 Bausch and Lomb Hydrogel-based Drug Delivery Device Product and Services
2.21.4 Bausch and Lomb Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 Bausch and Lomb Recent Developments/Updates
2.22 Ferring B.V
2.22.1 Ferring B.V Details
2.22.2 Ferring B.V Major Business
2.22.3 Ferring B.V Hydrogel-based Drug Delivery Device Product and Services
2.22.4 Ferring B.V Hydrogel-based Drug Delivery Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 Ferring B.V Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HYDROGEL-BASED DRUG DELIVERY DEVICE BY MANUFACTURER
3.1 Global Hydrogel-based Drug Delivery Device Sales Quantity by Manufacturer (2020-2025)
3.2 Global Hydrogel-based Drug Delivery Device Revenue by Manufacturer (2020-2025)
3.3 Global Hydrogel-based Drug Delivery Device Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Hydrogel-based Drug Delivery Device by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Hydrogel-based Drug Delivery Device Manufacturer Market Share in 2024
3.4.3 Top 6 Hydrogel-based Drug Delivery Device Manufacturer Market Share in 2024
3.5 Hydrogel-based Drug Delivery Device Market: Overall Company Footprint Analysis
3.5.1 Hydrogel-based Drug Delivery Device Market: Region Footprint
3.5.2 Hydrogel-based Drug Delivery Device Market: Company Product Type Footprint
3.5.3 Hydrogel-based Drug Delivery Device Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Hydrogel-based Drug Delivery Device Market Size by Region
4.1.1 Global Hydrogel-based Drug Delivery Device Sales Quantity by Region (2020-2031)
4.1.2 Global Hydrogel-based Drug Delivery Device Consumption Value by Region (2020-2031)
4.1.3 Global Hydrogel-based Drug Delivery Device Average Price by Region (2020-2031)
4.2 North America Hydrogel-based Drug Delivery Device Consumption Value (2020-2031)
4.3 Europe Hydrogel-based Drug Delivery Device Consumption Value (2020-2031)
4.4 Asia-Pacific Hydrogel-based Drug Delivery Device Consumption Value (2020-2031)
4.5 South America Hydrogel-based Drug Delivery Device Consumption Value (2020-2031)
4.6 Middle East & Africa Hydrogel-based Drug Delivery Device Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2031)
5.2 Global Hydrogel-based Drug Delivery Device Consumption Value by Type (2020-2031)
5.3 Global Hydrogel-based Drug Delivery Device Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2031)
6.2 Global Hydrogel-based Drug Delivery Device Consumption Value by Application (2020-2031)
6.3 Global Hydrogel-based Drug Delivery Device Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2031)
7.2 North America Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2031)
7.3 North America Hydrogel-based Drug Delivery Device Market Size by Country
7.3.1 North America Hydrogel-based Drug Delivery Device Sales Quantity by Country (2020-2031)
7.3.2 North America Hydrogel-based Drug Delivery Device Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2031)
8.2 Europe Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2031)
8.3 Europe Hydrogel-based Drug Delivery Device Market Size by Country
8.3.1 Europe Hydrogel-based Drug Delivery Device Sales Quantity by Country (2020-2031)
8.3.2 Europe Hydrogel-based Drug Delivery Device Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Hydrogel-based Drug Delivery Device Market Size by Region
9.3.1 Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Hydrogel-based Drug Delivery Device Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2031)
10.2 South America Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2031)
10.3 South America Hydrogel-based Drug Delivery Device Market Size by Country
10.3.1 South America Hydrogel-based Drug Delivery Device Sales Quantity by Country (2020-2031)
10.3.2 South America Hydrogel-based Drug Delivery Device Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Hydrogel-based Drug Delivery Device Market Size by Country
11.3.1 Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Hydrogel-based Drug Delivery Device Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Hydrogel-based Drug Delivery Device Market Drivers
12.2 Hydrogel-based Drug Delivery Device Market Restraints
12.3 Hydrogel-based Drug Delivery Device Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Hydrogel-based Drug Delivery Device and Key Manufacturers
13.2 Manufacturing Costs Percentage of Hydrogel-based Drug Delivery Device
13.3 Hydrogel-based Drug Delivery Device Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Hydrogel-based Drug Delivery Device Typical Distributors
14.3 Hydrogel-based Drug Delivery Device Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Hydrogel-based Drug Delivery Device Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Hydrogel-based Drug Delivery Device Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. AstraZeneca Plc. Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Plc. Major Business
Table 5. AstraZeneca Plc. Hydrogel-based Drug Delivery Device Product and Services
Table 6. AstraZeneca Plc. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. AstraZeneca Plc. Recent Developments/Updates
Table 8. Columbia Laboratories Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Columbia Laboratories Inc. Major Business
Table 10. Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Product and Services
Table 11. Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Columbia Laboratories Inc. Recent Developments/Updates
Table 13. Mylan Basic Information, Manufacturing Base and Competitors
Table 14. Mylan Major Business
Table 15. Mylan Hydrogel-based Drug Delivery Device Product and Services
Table 16. Mylan Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Mylan Recent Developments/Updates
Table 18. Teva Pharmaceuticals USA Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Teva Pharmaceuticals USA Inc. Major Business
Table 20. Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Product and Services
Table 21. Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Teva Pharmaceuticals USA Inc. Recent Developments/Updates
Table 23. Blairex Laboratories Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Blairex Laboratories Inc. Major Business
Table 25. Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Product and Services
Table 26. Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Blairex Laboratories Inc. Recent Developments/Updates
Table 28. ARx LLC. Basic Information, Manufacturing Base and Competitors
Table 29. ARx LLC. Major Business
Table 30. ARx LLC. Hydrogel-based Drug Delivery Device Product and Services
Table 31. ARx LLC. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. ARx LLC. Recent Developments/Updates
Table 33. Endo International plc Basic Information, Manufacturing Base and Competitors
Table 34. Endo International plc Major Business
Table 35. Endo International plc Hydrogel-based Drug Delivery Device Product and Services
Table 36. Endo International plc Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Endo International plc Recent Developments/Updates
Table 38. BioDelivery Sciences International Inc. Basic Information, Manufacturing Base and Competitors
Table 39. BioDelivery Sciences International Inc. Major Business
Table 40. BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Product and Services
Table 41. BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. BioDelivery Sciences International Inc. Recent Developments/Updates
Table 43. Indivior PLC Basic Information, Manufacturing Base and Competitors
Table 44. Indivior PLC Major Business
Table 45. Indivior PLC Hydrogel-based Drug Delivery Device Product and Services
Table 46. Indivior PLC Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Indivior PLC Recent Developments/Updates
Table 48. GSK Plc Basic Information, Manufacturing Base and Competitors
Table 49. GSK Plc Major Business
Table 50. GSK Plc Hydrogel-based Drug Delivery Device Product and Services
Table 51. GSK Plc Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. GSK Plc Recent Developments/Updates
Table 53. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Pfizer Inc. Major Business
Table 55. Pfizer Inc. Hydrogel-based Drug Delivery Device Product and Services
Table 56. Pfizer Inc. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Pfizer Inc. Recent Developments/Updates
Table 58. Aquestive Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 59. Aquestive Therapeutics Inc. Major Business
Table 60. Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Product and Services
Table 61. Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Aquestive Therapeutics Inc. Recent Developments/Updates
Table 63. ZIM LABORATORIES LIMITED Basic Information, Manufacturing Base and Competitors
Table 64. ZIM LABORATORIES LIMITED Major Business
Table 65. ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Product and Services
Table 66. ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. ZIM LABORATORIES LIMITED Recent Developments/Updates
Table 68. IntelGenx Corp. Basic Information, Manufacturing Base and Competitors
Table 69. IntelGenx Corp. Major Business
Table 70. IntelGenx Corp. Hydrogel-based Drug Delivery Device Product and Services
Table 71. IntelGenx Corp. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. IntelGenx Corp. Recent Developments/Updates
Table 73. NEXGEL Basic Information, Manufacturing Base and Competitors
Table 74. NEXGEL Major Business
Table 75. NEXGEL Hydrogel-based Drug Delivery Device Product and Services
Table 76. NEXGEL Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. NEXGEL Recent Developments/Updates
Table 78. Bliss GVS Pharma Ltd. Basic Information, Manufacturing Base and Competitors
Table 79. Bliss GVS Pharma Ltd. Major Business
Table 80. Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Product and Services
Table 81. Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. Bliss GVS Pharma Ltd. Recent Developments/Updates
Table 83. Teika Pharmaceutical Co. Ltd. Basic Information, Manufacturing Base and Competitors
Table 84. Teika Pharmaceutical Co. Ltd. Major Business
Table 85. Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Product and Services
Table 86. Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 87. Teika Pharmaceutical Co. Ltd. Recent Developments/Updates
Table 88. Medherant Limited Basic Information, Manufacturing Base and Competitors
Table 89. Medherant Limited Major Business
Table 90. Medherant Limited Hydrogel-based Drug Delivery Device Product and Services
Table 91. Medherant Limited Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 92. Medherant Limited Recent Developments/Updates
Table 93. Galderma Basic Information, Manufacturing Base and Competitors
Table 94. Galderma Major Business
Table 95. Galderma Hydrogel-based Drug Delivery Device Product and Services
Table 96. Galderma Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 97. Galderma Recent Developments/Updates
Table 98. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 99. Johnson & Johnson Major Business
Table 100. Johnson & Johnson Hydrogel-based Drug Delivery Device Product and Services
Table 101. Johnson & Johnson Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 102. Johnson & Johnson Recent Developments/Updates
Table 103. Bausch and Lomb Basic Information, Manufacturing Base and Competitors
Table 104. Bausch and Lomb Major Business
Table 105. Bausch and Lomb Hydrogel-based Drug Delivery Device Product and Services
Table 106. Bausch and Lomb Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 107. Bausch and Lomb Recent Developments/Updates
Table 108. Ferring B.V Basic Information, Manufacturing Base and Competitors
Table 109. Ferring B.V Major Business
Table 110. Ferring B.V Hydrogel-based Drug Delivery Device Product and Services
Table 111. Ferring B.V Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 112. Ferring B.V Recent Developments/Updates
Table 113. Global Hydrogel-based Drug Delivery Device Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 114. Global Hydrogel-based Drug Delivery Device Revenue by Manufacturer (2020-2025) & (USD Million)
Table 115. Global Hydrogel-based Drug Delivery Device Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 116. Market Position of Manufacturers in Hydrogel-based Drug Delivery Device, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 117. Head Office and Hydrogel-based Drug Delivery Device Production Site of Key Manufacturer
Table 118. Hydrogel-based Drug Delivery Device Market: Company Product Type Footprint
Table 119. Hydrogel-based Drug Delivery Device Market: Company Product Application Footprint
Table 120. Hydrogel-based Drug Delivery Device New Market Entrants and Barriers to Market Entry
Table 121. Hydrogel-based Drug Delivery Device Mergers, Acquisition, Agreements, and Collaborations
Table 122. Global Hydrogel-based Drug Delivery Device Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 123. Global Hydrogel-based Drug Delivery Device Sales Quantity by Region (2020-2025) & (K Units)
Table 124. Global Hydrogel-based Drug Delivery Device Sales Quantity by Region (2026-2031) & (K Units)
Table 125. Global Hydrogel-based Drug Delivery Device Consumption Value by Region (2020-2025) & (USD Million)
Table 126. Global Hydrogel-based Drug Delivery Device Consumption Value by Region (2026-2031) & (USD Million)
Table 127. Global Hydrogel-based Drug Delivery Device Average Price by Region (2020-2025) & (US$/Unit)
Table 128. Global Hydrogel-based Drug Delivery Device Average Price by Region (2026-2031) & (US$/Unit)
Table 129. Global Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2025) & (K Units)
Table 130. Global Hydrogel-based Drug Delivery Device Sales Quantity by Type (2026-2031) & (K Units)
Table 131. Global Hydrogel-based Drug Delivery Device Consumption Value by Type (2020-2025) & (USD Million)
Table 132. Global Hydrogel-based Drug Delivery Device Consumption Value by Type (2026-2031) & (USD Million)
Table 133. Global Hydrogel-based Drug Delivery Device Average Price by Type (2020-2025) & (US$/Unit)
Table 134. Global Hydrogel-based Drug Delivery Device Average Price by Type (2026-2031) & (US$/Unit)
Table 135. Global Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2025) & (K Units)
Table 136. Global Hydrogel-based Drug Delivery Device Sales Quantity by Application (2026-2031) & (K Units)
Table 137. Global Hydrogel-based Drug Delivery Device Consumption Value by Application (2020-2025) & (USD Million)
Table 138. Global Hydrogel-based Drug Delivery Device Consumption Value by Application (2026-2031) & (USD Million)
Table 139. Global Hydrogel-based Drug Delivery Device Average Price by Application (2020-2025) & (US$/Unit)
Table 140. Global Hydrogel-based Drug Delivery Device Average Price by Application (2026-2031) & (US$/Unit)
Table 141. North America Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2025) & (K Units)
Table 142. North America Hydrogel-based Drug Delivery Device Sales Quantity by Type (2026-2031) & (K Units)
Table 143. North America Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2025) & (K Units)
Table 144. North America Hydrogel-based Drug Delivery Device Sales Quantity by Application (2026-2031) & (K Units)
Table 145. North America Hydrogel-based Drug Delivery Device Sales Quantity by Country (2020-2025) & (K Units)
Table 146. North America Hydrogel-based Drug Delivery Device Sales Quantity by Country (2026-2031) & (K Units)
Table 147. North America Hydrogel-based Drug Delivery Device Consumption Value by Country (2020-2025) & (USD Million)
Table 148. North America Hydrogel-based Drug Delivery Device Consumption Value by Country (2026-2031) & (USD Million)
Table 149. Europe Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2025) & (K Units)
Table 150. Europe Hydrogel-based Drug Delivery Device Sales Quantity by Type (2026-2031) & (K Units)
Table 151. Europe Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2025) & (K Units)
Table 152. Europe Hydrogel-based Drug Delivery Device Sales Quantity by Application (2026-2031) & (K Units)
Table 153. Europe Hydrogel-based Drug Delivery Device Sales Quantity by Country (2020-2025) & (K Units)
Table 154. Europe Hydrogel-based Drug Delivery Device Sales Quantity by Country (2026-2031) & (K Units)
Table 155. Europe Hydrogel-based Drug Delivery Device Consumption Value by Country (2020-2025) & (USD Million)
Table 156. Europe Hydrogel-based Drug Delivery Device Consumption Value by Country (2026-2031) & (USD Million)
Table 157. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2025) & (K Units)
Table 158. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity by Type (2026-2031) & (K Units)
Table 159. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2025) & (K Units)
Table 160. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity by Application (2026-2031) & (K Units)
Table 161. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity by Region (2020-2025) & (K Units)
Table 162. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity by Region (2026-2031) & (K Units)
Table 163. Asia-Pacific Hydrogel-based Drug Delivery Device Consumption Value by Region (2020-2025) & (USD Million)
Table 164. Asia-Pacific Hydrogel-based Drug Delivery Device Consumption Value by Region (2026-2031) & (USD Million)
Table 165. South America Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2025) & (K Units)
Table 166. South America Hydrogel-based Drug Delivery Device Sales Quantity by Type (2026-2031) & (K Units)
Table 167. South America Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2025) & (K Units)
Table 168. South America Hydrogel-based Drug Delivery Device Sales Quantity by Application (2026-2031) & (K Units)
Table 169. South America Hydrogel-based Drug Delivery Device Sales Quantity by Country (2020-2025) & (K Units)
Table 170. South America Hydrogel-based Drug Delivery Device Sales Quantity by Country (2026-2031) & (K Units)
Table 171. South America Hydrogel-based Drug Delivery Device Consumption Value by Country (2020-2025) & (USD Million)
Table 172. South America Hydrogel-based Drug Delivery Device Consumption Value by Country (2026-2031) & (USD Million)
Table 173. Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2025) & (K Units)
Table 174. Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity by Type (2026-2031) & (K Units)
Table 175. Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2025) & (K Units)
Table 176. Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity by Application (2026-2031) & (K Units)
Table 177. Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity by Country (2020-2025) & (K Units)
Table 178. Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity by Country (2026-2031) & (K Units)
Table 179. Middle East & Africa Hydrogel-based Drug Delivery Device Consumption Value by Country (2020-2025) & (USD Million)
Table 180. Middle East & Africa Hydrogel-based Drug Delivery Device Consumption Value by Country (2026-2031) & (USD Million)
Table 181. Hydrogel-based Drug Delivery Device Raw Material
Table 182. Key Manufacturers of Hydrogel-based Drug Delivery Device Raw Materials
Table 183. Hydrogel-based Drug Delivery Device Typical Distributors
Table 184. Hydrogel-based Drug Delivery Device Typical Customers
Table 1. Global Hydrogel-based Drug Delivery Device Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Hydrogel-based Drug Delivery Device Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. AstraZeneca Plc. Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Plc. Major Business
Table 5. AstraZeneca Plc. Hydrogel-based Drug Delivery Device Product and Services
Table 6. AstraZeneca Plc. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. AstraZeneca Plc. Recent Developments/Updates
Table 8. Columbia Laboratories Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Columbia Laboratories Inc. Major Business
Table 10. Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Product and Services
Table 11. Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Columbia Laboratories Inc. Recent Developments/Updates
Table 13. Mylan Basic Information, Manufacturing Base and Competitors
Table 14. Mylan Major Business
Table 15. Mylan Hydrogel-based Drug Delivery Device Product and Services
Table 16. Mylan Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Mylan Recent Developments/Updates
Table 18. Teva Pharmaceuticals USA Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Teva Pharmaceuticals USA Inc. Major Business
Table 20. Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Product and Services
Table 21. Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Teva Pharmaceuticals USA Inc. Recent Developments/Updates
Table 23. Blairex Laboratories Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Blairex Laboratories Inc. Major Business
Table 25. Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Product and Services
Table 26. Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Blairex Laboratories Inc. Recent Developments/Updates
Table 28. ARx LLC. Basic Information, Manufacturing Base and Competitors
Table 29. ARx LLC. Major Business
Table 30. ARx LLC. Hydrogel-based Drug Delivery Device Product and Services
Table 31. ARx LLC. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. ARx LLC. Recent Developments/Updates
Table 33. Endo International plc Basic Information, Manufacturing Base and Competitors
Table 34. Endo International plc Major Business
Table 35. Endo International plc Hydrogel-based Drug Delivery Device Product and Services
Table 36. Endo International plc Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Endo International plc Recent Developments/Updates
Table 38. BioDelivery Sciences International Inc. Basic Information, Manufacturing Base and Competitors
Table 39. BioDelivery Sciences International Inc. Major Business
Table 40. BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Product and Services
Table 41. BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. BioDelivery Sciences International Inc. Recent Developments/Updates
Table 43. Indivior PLC Basic Information, Manufacturing Base and Competitors
Table 44. Indivior PLC Major Business
Table 45. Indivior PLC Hydrogel-based Drug Delivery Device Product and Services
Table 46. Indivior PLC Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Indivior PLC Recent Developments/Updates
Table 48. GSK Plc Basic Information, Manufacturing Base and Competitors
Table 49. GSK Plc Major Business
Table 50. GSK Plc Hydrogel-based Drug Delivery Device Product and Services
Table 51. GSK Plc Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. GSK Plc Recent Developments/Updates
Table 53. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Pfizer Inc. Major Business
Table 55. Pfizer Inc. Hydrogel-based Drug Delivery Device Product and Services
Table 56. Pfizer Inc. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Pfizer Inc. Recent Developments/Updates
Table 58. Aquestive Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 59. Aquestive Therapeutics Inc. Major Business
Table 60. Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Product and Services
Table 61. Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Aquestive Therapeutics Inc. Recent Developments/Updates
Table 63. ZIM LABORATORIES LIMITED Basic Information, Manufacturing Base and Competitors
Table 64. ZIM LABORATORIES LIMITED Major Business
Table 65. ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Product and Services
Table 66. ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. ZIM LABORATORIES LIMITED Recent Developments/Updates
Table 68. IntelGenx Corp. Basic Information, Manufacturing Base and Competitors
Table 69. IntelGenx Corp. Major Business
Table 70. IntelGenx Corp. Hydrogel-based Drug Delivery Device Product and Services
Table 71. IntelGenx Corp. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. IntelGenx Corp. Recent Developments/Updates
Table 73. NEXGEL Basic Information, Manufacturing Base and Competitors
Table 74. NEXGEL Major Business
Table 75. NEXGEL Hydrogel-based Drug Delivery Device Product and Services
Table 76. NEXGEL Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. NEXGEL Recent Developments/Updates
Table 78. Bliss GVS Pharma Ltd. Basic Information, Manufacturing Base and Competitors
Table 79. Bliss GVS Pharma Ltd. Major Business
Table 80. Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Product and Services
Table 81. Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. Bliss GVS Pharma Ltd. Recent Developments/Updates
Table 83. Teika Pharmaceutical Co. Ltd. Basic Information, Manufacturing Base and Competitors
Table 84. Teika Pharmaceutical Co. Ltd. Major Business
Table 85. Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Product and Services
Table 86. Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 87. Teika Pharmaceutical Co. Ltd. Recent Developments/Updates
Table 88. Medherant Limited Basic Information, Manufacturing Base and Competitors
Table 89. Medherant Limited Major Business
Table 90. Medherant Limited Hydrogel-based Drug Delivery Device Product and Services
Table 91. Medherant Limited Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 92. Medherant Limited Recent Developments/Updates
Table 93. Galderma Basic Information, Manufacturing Base and Competitors
Table 94. Galderma Major Business
Table 95. Galderma Hydrogel-based Drug Delivery Device Product and Services
Table 96. Galderma Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 97. Galderma Recent Developments/Updates
Table 98. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 99. Johnson & Johnson Major Business
Table 100. Johnson & Johnson Hydrogel-based Drug Delivery Device Product and Services
Table 101. Johnson & Johnson Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 102. Johnson & Johnson Recent Developments/Updates
Table 103. Bausch and Lomb Basic Information, Manufacturing Base and Competitors
Table 104. Bausch and Lomb Major Business
Table 105. Bausch and Lomb Hydrogel-based Drug Delivery Device Product and Services
Table 106. Bausch and Lomb Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 107. Bausch and Lomb Recent Developments/Updates
Table 108. Ferring B.V Basic Information, Manufacturing Base and Competitors
Table 109. Ferring B.V Major Business
Table 110. Ferring B.V Hydrogel-based Drug Delivery Device Product and Services
Table 111. Ferring B.V Hydrogel-based Drug Delivery Device Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 112. Ferring B.V Recent Developments/Updates
Table 113. Global Hydrogel-based Drug Delivery Device Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 114. Global Hydrogel-based Drug Delivery Device Revenue by Manufacturer (2020-2025) & (USD Million)
Table 115. Global Hydrogel-based Drug Delivery Device Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 116. Market Position of Manufacturers in Hydrogel-based Drug Delivery Device, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 117. Head Office and Hydrogel-based Drug Delivery Device Production Site of Key Manufacturer
Table 118. Hydrogel-based Drug Delivery Device Market: Company Product Type Footprint
Table 119. Hydrogel-based Drug Delivery Device Market: Company Product Application Footprint
Table 120. Hydrogel-based Drug Delivery Device New Market Entrants and Barriers to Market Entry
Table 121. Hydrogel-based Drug Delivery Device Mergers, Acquisition, Agreements, and Collaborations
Table 122. Global Hydrogel-based Drug Delivery Device Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 123. Global Hydrogel-based Drug Delivery Device Sales Quantity by Region (2020-2025) & (K Units)
Table 124. Global Hydrogel-based Drug Delivery Device Sales Quantity by Region (2026-2031) & (K Units)
Table 125. Global Hydrogel-based Drug Delivery Device Consumption Value by Region (2020-2025) & (USD Million)
Table 126. Global Hydrogel-based Drug Delivery Device Consumption Value by Region (2026-2031) & (USD Million)
Table 127. Global Hydrogel-based Drug Delivery Device Average Price by Region (2020-2025) & (US$/Unit)
Table 128. Global Hydrogel-based Drug Delivery Device Average Price by Region (2026-2031) & (US$/Unit)
Table 129. Global Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2025) & (K Units)
Table 130. Global Hydrogel-based Drug Delivery Device Sales Quantity by Type (2026-2031) & (K Units)
Table 131. Global Hydrogel-based Drug Delivery Device Consumption Value by Type (2020-2025) & (USD Million)
Table 132. Global Hydrogel-based Drug Delivery Device Consumption Value by Type (2026-2031) & (USD Million)
Table 133. Global Hydrogel-based Drug Delivery Device Average Price by Type (2020-2025) & (US$/Unit)
Table 134. Global Hydrogel-based Drug Delivery Device Average Price by Type (2026-2031) & (US$/Unit)
Table 135. Global Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2025) & (K Units)
Table 136. Global Hydrogel-based Drug Delivery Device Sales Quantity by Application (2026-2031) & (K Units)
Table 137. Global Hydrogel-based Drug Delivery Device Consumption Value by Application (2020-2025) & (USD Million)
Table 138. Global Hydrogel-based Drug Delivery Device Consumption Value by Application (2026-2031) & (USD Million)
Table 139. Global Hydrogel-based Drug Delivery Device Average Price by Application (2020-2025) & (US$/Unit)
Table 140. Global Hydrogel-based Drug Delivery Device Average Price by Application (2026-2031) & (US$/Unit)
Table 141. North America Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2025) & (K Units)
Table 142. North America Hydrogel-based Drug Delivery Device Sales Quantity by Type (2026-2031) & (K Units)
Table 143. North America Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2025) & (K Units)
Table 144. North America Hydrogel-based Drug Delivery Device Sales Quantity by Application (2026-2031) & (K Units)
Table 145. North America Hydrogel-based Drug Delivery Device Sales Quantity by Country (2020-2025) & (K Units)
Table 146. North America Hydrogel-based Drug Delivery Device Sales Quantity by Country (2026-2031) & (K Units)
Table 147. North America Hydrogel-based Drug Delivery Device Consumption Value by Country (2020-2025) & (USD Million)
Table 148. North America Hydrogel-based Drug Delivery Device Consumption Value by Country (2026-2031) & (USD Million)
Table 149. Europe Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2025) & (K Units)
Table 150. Europe Hydrogel-based Drug Delivery Device Sales Quantity by Type (2026-2031) & (K Units)
Table 151. Europe Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2025) & (K Units)
Table 152. Europe Hydrogel-based Drug Delivery Device Sales Quantity by Application (2026-2031) & (K Units)
Table 153. Europe Hydrogel-based Drug Delivery Device Sales Quantity by Country (2020-2025) & (K Units)
Table 154. Europe Hydrogel-based Drug Delivery Device Sales Quantity by Country (2026-2031) & (K Units)
Table 155. Europe Hydrogel-based Drug Delivery Device Consumption Value by Country (2020-2025) & (USD Million)
Table 156. Europe Hydrogel-based Drug Delivery Device Consumption Value by Country (2026-2031) & (USD Million)
Table 157. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2025) & (K Units)
Table 158. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity by Type (2026-2031) & (K Units)
Table 159. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2025) & (K Units)
Table 160. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity by Application (2026-2031) & (K Units)
Table 161. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity by Region (2020-2025) & (K Units)
Table 162. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity by Region (2026-2031) & (K Units)
Table 163. Asia-Pacific Hydrogel-based Drug Delivery Device Consumption Value by Region (2020-2025) & (USD Million)
Table 164. Asia-Pacific Hydrogel-based Drug Delivery Device Consumption Value by Region (2026-2031) & (USD Million)
Table 165. South America Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2025) & (K Units)
Table 166. South America Hydrogel-based Drug Delivery Device Sales Quantity by Type (2026-2031) & (K Units)
Table 167. South America Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2025) & (K Units)
Table 168. South America Hydrogel-based Drug Delivery Device Sales Quantity by Application (2026-2031) & (K Units)
Table 169. South America Hydrogel-based Drug Delivery Device Sales Quantity by Country (2020-2025) & (K Units)
Table 170. South America Hydrogel-based Drug Delivery Device Sales Quantity by Country (2026-2031) & (K Units)
Table 171. South America Hydrogel-based Drug Delivery Device Consumption Value by Country (2020-2025) & (USD Million)
Table 172. South America Hydrogel-based Drug Delivery Device Consumption Value by Country (2026-2031) & (USD Million)
Table 173. Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity by Type (2020-2025) & (K Units)
Table 174. Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity by Type (2026-2031) & (K Units)
Table 175. Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity by Application (2020-2025) & (K Units)
Table 176. Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity by Application (2026-2031) & (K Units)
Table 177. Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity by Country (2020-2025) & (K Units)
Table 178. Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity by Country (2026-2031) & (K Units)
Table 179. Middle East & Africa Hydrogel-based Drug Delivery Device Consumption Value by Country (2020-2025) & (USD Million)
Table 180. Middle East & Africa Hydrogel-based Drug Delivery Device Consumption Value by Country (2026-2031) & (USD Million)
Table 181. Hydrogel-based Drug Delivery Device Raw Material
Table 182. Key Manufacturers of Hydrogel-based Drug Delivery Device Raw Materials
Table 183. Hydrogel-based Drug Delivery Device Typical Distributors
Table 184. Hydrogel-based Drug Delivery Device Typical Customers
LIST OF FIGURES
Figure 1. Hydrogel-based Drug Delivery Device Picture
Figure 2. Global Hydrogel-based Drug Delivery Device Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Type in 2024
Figure 4. Oral Examples
Figure 5. Buccal Examples
Figure 6. Rectal Examples
Figure 7. Vaginal Examples
Figure 8. Other Examples
Figure 9. Global Hydrogel-based Drug Delivery Device Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 10. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Application in 2024
Figure 11. Hospital Examples
Figure 12. Clinic Examples
Figure 13. Other Examples
Figure 14. Global Hydrogel-based Drug Delivery Device Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Hydrogel-based Drug Delivery Device Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 16. Global Hydrogel-based Drug Delivery Device Sales Quantity (2020-2031) & (K Units)
Figure 17. Global Hydrogel-based Drug Delivery Device Price (2020-2031) & (US$/Unit)
Figure 18. Global Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Manufacturer in 2024
Figure 19. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Manufacturer in 2024
Figure 20. Producer Shipments of Hydrogel-based Drug Delivery Device by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 21. Top 3 Hydrogel-based Drug Delivery Device Manufacturer (Revenue) Market Share in 2024
Figure 22. Top 6 Hydrogel-based Drug Delivery Device Manufacturer (Revenue) Market Share in 2024
Figure 23. Global Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Region (2020-2031)
Figure 24. Global Hydrogel-based Drug Delivery Device Consumption Value Market Share by Region (2020-2031)
Figure 25. North America Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 26. Europe Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 27. Asia-Pacific Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 28. South America Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 29. Middle East & Africa Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 30. Global Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Type (2020-2031)
Figure 31. Global Hydrogel-based Drug Delivery Device Consumption Value Market Share by Type (2020-2031)
Figure 32. Global Hydrogel-based Drug Delivery Device Average Price by Type (2020-2031) & (US$/Unit)
Figure 33. Global Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Application (2020-2031)
Figure 34. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Application (2020-2031)
Figure 35. Global Hydrogel-based Drug Delivery Device Average Price by Application (2020-2031) & (US$/Unit)
Figure 36. North America Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Type (2020-2031)
Figure 37. North America Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Application (2020-2031)
Figure 38. North America Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Country (2020-2031)
Figure 39. North America Hydrogel-based Drug Delivery Device Consumption Value Market Share by Country (2020-2031)
Figure 40. United States Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 41. Canada Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 42. Mexico Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 43. Europe Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Type (2020-2031)
Figure 44. Europe Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Application (2020-2031)
Figure 45. Europe Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Country (2020-2031)
Figure 46. Europe Hydrogel-based Drug Delivery Device Consumption Value Market Share by Country (2020-2031)
Figure 47. Germany Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 48. France Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 49. United Kingdom Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 50. Russia Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 51. Italy Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 52. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Type (2020-2031)
Figure 53. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Application (2020-2031)
Figure 54. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Region (2020-2031)
Figure 55. Asia-Pacific Hydrogel-based Drug Delivery Device Consumption Value Market Share by Region (2020-2031)
Figure 56. China Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 57. Japan Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 58. South Korea Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 59. India Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 60. Southeast Asia Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 61. Australia Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 62. South America Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Type (2020-2031)
Figure 63. South America Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Application (2020-2031)
Figure 64. South America Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Country (2020-2031)
Figure 65. South America Hydrogel-based Drug Delivery Device Consumption Value Market Share by Country (2020-2031)
Figure 66. Brazil Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 67. Argentina Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 68. Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Type (2020-2031)
Figure 69. Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Application (2020-2031)
Figure 70. Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Country (2020-2031)
Figure 71. Middle East & Africa Hydrogel-based Drug Delivery Device Consumption Value Market Share by Country (2020-2031)
Figure 72. Turkey Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 73. Egypt Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 74. Saudi Arabia Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 75. South Africa Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 76. Hydrogel-based Drug Delivery Device Market Drivers
Figure 77. Hydrogel-based Drug Delivery Device Market Restraints
Figure 78. Hydrogel-based Drug Delivery Device Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Hydrogel-based Drug Delivery Device in 2024
Figure 81. Manufacturing Process Analysis of Hydrogel-based Drug Delivery Device
Figure 82. Hydrogel-based Drug Delivery Device Industrial Chain
Figure 83. Sales Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. Hydrogel-based Drug Delivery Device Picture
Figure 2. Global Hydrogel-based Drug Delivery Device Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Type in 2024
Figure 4. Oral Examples
Figure 5. Buccal Examples
Figure 6. Rectal Examples
Figure 7. Vaginal Examples
Figure 8. Other Examples
Figure 9. Global Hydrogel-based Drug Delivery Device Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 10. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Application in 2024
Figure 11. Hospital Examples
Figure 12. Clinic Examples
Figure 13. Other Examples
Figure 14. Global Hydrogel-based Drug Delivery Device Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Hydrogel-based Drug Delivery Device Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 16. Global Hydrogel-based Drug Delivery Device Sales Quantity (2020-2031) & (K Units)
Figure 17. Global Hydrogel-based Drug Delivery Device Price (2020-2031) & (US$/Unit)
Figure 18. Global Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Manufacturer in 2024
Figure 19. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Manufacturer in 2024
Figure 20. Producer Shipments of Hydrogel-based Drug Delivery Device by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 21. Top 3 Hydrogel-based Drug Delivery Device Manufacturer (Revenue) Market Share in 2024
Figure 22. Top 6 Hydrogel-based Drug Delivery Device Manufacturer (Revenue) Market Share in 2024
Figure 23. Global Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Region (2020-2031)
Figure 24. Global Hydrogel-based Drug Delivery Device Consumption Value Market Share by Region (2020-2031)
Figure 25. North America Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 26. Europe Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 27. Asia-Pacific Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 28. South America Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 29. Middle East & Africa Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 30. Global Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Type (2020-2031)
Figure 31. Global Hydrogel-based Drug Delivery Device Consumption Value Market Share by Type (2020-2031)
Figure 32. Global Hydrogel-based Drug Delivery Device Average Price by Type (2020-2031) & (US$/Unit)
Figure 33. Global Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Application (2020-2031)
Figure 34. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Application (2020-2031)
Figure 35. Global Hydrogel-based Drug Delivery Device Average Price by Application (2020-2031) & (US$/Unit)
Figure 36. North America Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Type (2020-2031)
Figure 37. North America Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Application (2020-2031)
Figure 38. North America Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Country (2020-2031)
Figure 39. North America Hydrogel-based Drug Delivery Device Consumption Value Market Share by Country (2020-2031)
Figure 40. United States Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 41. Canada Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 42. Mexico Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 43. Europe Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Type (2020-2031)
Figure 44. Europe Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Application (2020-2031)
Figure 45. Europe Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Country (2020-2031)
Figure 46. Europe Hydrogel-based Drug Delivery Device Consumption Value Market Share by Country (2020-2031)
Figure 47. Germany Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 48. France Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 49. United Kingdom Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 50. Russia Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 51. Italy Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 52. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Type (2020-2031)
Figure 53. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Application (2020-2031)
Figure 54. Asia-Pacific Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Region (2020-2031)
Figure 55. Asia-Pacific Hydrogel-based Drug Delivery Device Consumption Value Market Share by Region (2020-2031)
Figure 56. China Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 57. Japan Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 58. South Korea Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 59. India Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 60. Southeast Asia Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 61. Australia Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 62. South America Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Type (2020-2031)
Figure 63. South America Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Application (2020-2031)
Figure 64. South America Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Country (2020-2031)
Figure 65. South America Hydrogel-based Drug Delivery Device Consumption Value Market Share by Country (2020-2031)
Figure 66. Brazil Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 67. Argentina Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 68. Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Type (2020-2031)
Figure 69. Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Application (2020-2031)
Figure 70. Middle East & Africa Hydrogel-based Drug Delivery Device Sales Quantity Market Share by Country (2020-2031)
Figure 71. Middle East & Africa Hydrogel-based Drug Delivery Device Consumption Value Market Share by Country (2020-2031)
Figure 72. Turkey Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 73. Egypt Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 74. Saudi Arabia Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 75. South Africa Hydrogel-based Drug Delivery Device Consumption Value (2020-2031) & (USD Million)
Figure 76. Hydrogel-based Drug Delivery Device Market Drivers
Figure 77. Hydrogel-based Drug Delivery Device Market Restraints
Figure 78. Hydrogel-based Drug Delivery Device Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Hydrogel-based Drug Delivery Device in 2024
Figure 81. Manufacturing Process Analysis of Hydrogel-based Drug Delivery Device
Figure 82. Hydrogel-based Drug Delivery Device Industrial Chain
Figure 83. Sales Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
